nVerses Capital’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,200
Closed -$45.2K 77
2024
Q3
$45.2K Buy
+1,200
New +$46.3K 0.02% 662

Other funds holding ATEX

nVerses Capital's ATEX Position: Q4 2024 in Review

nVerses Capital sold out of Anterix (ATEX) in Q4 2024, closing a stake of 1,200 shares — an estimated $45.2K sold.

nVerses Capital first reported a position in ATEX in Q3 2024 and held it in 1 quarter. The position peaked at $45.2K in Q3 2024. 115 funds tracked by Wall St. Rank hold ATEX as of Q4 2024.

  • nVerses Capital reported no remaining Anterix position as of Q4 2024 after selling out during the quarter.
  • nVerses Capital sold 1,200 Anterix shares in Q4 2024, an estimated $45.2K.
  • nVerses Capital first reported a position in Anterix in Q3 2024 and held it in 1 quarter.
  • nVerses Capital's Anterix position peaked at $45.2K in Q3 2024.
  • 115 funds tracked by Wall St. Rank held Anterix as of Q4 2024.

Based on nVerses Capital's 13F filing for Q4 2024.